Source: StreetInsider

Press Release: Oaktree : Oaktree Acquisition Corp. III Life Sciences Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 16, 2024

LOS ANGELES--(BUSINESS WIRE)-- Oaktree Acquisition Corp. III Life Sciences (the Company) today announced that, commencing December 16, 2024, holders of the units sold in the Company's initial public offering may elect to separately trade the...

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
Robert O'Leary's photo - Co-CEO of Oaktree

Co-CEO

Robert O'Leary

CEO Approval Rating

83/100

Read more